Latest Breaking News On - Josephine belluardo - Page 3 : comparemela.com

Arrowhead Pharmaceuticals to Present Interim Phase 2 Clinical Data at AHA 2022 on SHASTA-2 Study of ARO-APOC3 and ARCHES-2 Study of ARO-ANG3

Arrowhead Pharmaceuticals to Present Interim Phase 2 Clinical Data at AHA 2022 on SHASTA-2 Study of ARO-APOC3 and ARCHES-2 Study of ARO-ANG3
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Christiem-ballantyne
Josephine-belluardo
Vince-anzalone
Roberts-rosenson
Brian-ritchie
American-heart-association
Lifesci-advisors
Arrowhead-pharmaceuticals-inc
Nasdaq
Exchange-commission

Arrowhead Pharmaceuticals to Participate in Upcoming September 2022 Conferences

Arrowhead Pharmaceuticals to Participate in Upcoming September 2022 Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Erik-bush
Vincent-anzalone
Josephine-belluardo
Vince-anzalone
Christopher-anzalone
Brian-ritchie
Morgan-stanley
Lifesci-advisors
Arrowhead-pharmaceuticals-inc
Group-vice
Nasdaq
Exchange-commission

Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MMP7 for Idiopathic Pulmonary Fibrosis

Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MMP7 for Idiopathic Pulmonary Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-zealand
Josephine-belluardo
Vince-anzalone
James-hamilton
Brian-ritchie
Standing-committee-on-therapeutic-trials
Lifesci-advisors
Arrowhead-pharmaceuticals-inc
Devices-safety-authority
Nasdaq
Exchange-commission
Arrowhead-pharmaceuticals

Takeda Pharmaceutical (TAK) and Arrowhead (ARWR) Announce Publication of Results from Phase 2 Study of Fazirsiran

Takeda Pharmaceutical (TAK) and Arrowhead (ARWR) Announce Publication of Results from Phase 2 Study of Fazirsiran
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
United-kingdom
London
City-of
Japanese
Pavel-strnad
Chinwe-ukomadu
Ritsuko-nomura
Josephine-belluardo
Vince-anzalone
Chris-stamm

Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine

Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Osaka
Japan
United-kingdom
London
City-of
Japanese
Pavel-strnad
Chinwe-ukomadu
Ritsuko-nomura
Josephine-belluardo
Vince-anzalone